J. Tomilson Hill logo

J. Tomilson Hill

Description

J. Tomilson Hill is President and Chief Executive Officer of BAAM, a Vice Chairman of The Blackstone Group and a member of the Board of Dire...

Investor Profile

J. Tomilson Hill has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does J. Tomilson Hill frequently co-invest with?

TV
North America, California, United States, San Francisco
Co-Investments: 1
NDFOS
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

Which angels does J. Tomilson Hill often collaborate with?

Shared Deals: 1

What are some of recent deals done by J. Tomilson Hill?

NeoTX Therapeutics

Rehovot, HaMerkaz, Israel

NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.

BiotechnologyHealth CareHealth DiagnosticsMedicalOncologyTherapeutics
Series CFeb 19, 2020
Amount Raised: $45,000,000